05 Nov, 2024 Poland - Life Sciences Monthly Brief, October 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
04 Sep, 2024 Poland - Life Sciences Monthly Brief, August 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
05 Sep, 2023 Poland - Life Sciences Monthly Brief, August 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our August monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Clinical...
11 May, 2023 Poland - Life Sciences Monthly Brief, April 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our April monthly briefing, which covers key updates and insights in the following areas: Medical devices; Clinical...
06 Feb, 2023 Poland - Life Sciences Monthly Brief, January 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Pharmacies; Clinical...
23 Jan, 2023 Pharmaceutical and medical sector in Poland, DLA Piper Report By Andrzej Balicki, Ph.D. Jolanta Dabrowicz We would like to invite you to read our report summarising the second edition of the DLA Piper survey "Pharmaceutical and medical sector...
08 Dec, 2022 Poland - Life Sciences Monthly Brief, November 2022 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less We first wrote about the planned amendments to the Pharmaceutical Law and certain other acts (the so-called Verticalisation Act) in...
12 Oct, 2022 The latest legislative changes in the pharmaceutical industry in Poland By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Urszula Grębowska In our latest report, we provide an update on the key legislative changes proposed and introduced in the pharmaceutical sector in Poland.
25 Apr, 2022 Poland: new medical devices law By Amelia Prawda Jolanta Dabrowicz On 7 April 2022, the Parliament passed the Act of 7 April 2022 on Medical Devices (the "Act"). It was signed by the President on 20...
06 Apr, 2022 New rules on the cultivation of medicinal cannabis in Poland By Amelia Prawda Jolanta Dabrowicz On 29 March 2022, the Polish President signed the Act of 24 March 2022 amending the Act on Counteracting Drug Addiction (the "Act"). The...
08 Nov, 2021 Poland discusses draft laws to facilitate the cultivation of hemp By Amelia Prawda Andrzej Balicki, Ph.D. On 20 April 2021, the draft bill on hemp ("Draft Bill") was submitted to the Sejm (the lower house of the Polish Parliament). The aim of...
15 Jul, 2021 DLA Piper Report - The COVID-19 pandemic and the pharmaceutical and medical sector in Poland By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Our report 'The COVID-19 pandemic and the pharmaceutical and medical sector in Poland' is the first that brings together the...
17 May, 2021 Poland: Draft bill on Clinical Trials By Amelia Prawda Andrzej Balicki, Ph.D. On 30 April 2021, the draft bill on clinical trials of medicinal products for human use (the “Draft bill”) was published. It intends to...